1. Show article details.

    Looking Into Stryker's Recent Short Interest

    Benzinga – 5:00 PM ET 07/01/2022

    Stryker's short percent of float has risen 22.22% since its last report. Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock.

  2. Show article details.

    If You Invested $100 In This Stock 15 Years Ago, You Would Have $300 Today

    Benzinga – 11:43 AM ET 07/01/2022

    Stryker has outperformed the market over the past 15 years by 1.53% on an annualized basis producing an average annual return of 7.72%. Currently, Stryker has a market capitalization of $75.26 billion. Buying $100 In SYK: If an investor had bought $100 of SYK stock 15 years ago, it would be worth $304.85 today based on a price of $199.02 for SYK at the time of writing.

  3. Show article details.

    Stryker to host conference call on July 26, 2022

    GlobeNewswire – 10:04 AM ET 06/30/2022

    Stryker announced that it will host a conference call on Tuesday, July 26, 2022 at 4:30 p.m., Eastern Time, to discuss the Company's operating results for the quarter ended June 30, 2022 and provide an operational update. To register for this conference call, please use the following link: Stryker's Q2 2022 Earnings call.

  4. Show article details.

    Stryker Launches “Free Your Feet” Campaign to Raise Awareness About New Bunion Treatments

    Business Wire – 8:33 AM ET 06/28/2022

    National Campaign to Feature Eye-Catching Experience in Four Major Metropolitan Cities Beginning June 27. Stryker, one of the world’s leading medical technology companies, today launched an experiential campaign to inspire consumers to explore new treatment options for bunions and increase awareness of the benefits of bunion surgery.

  5. Show article details.

    Stryker's debut at World Intelligence Congress: Bringing Stryker's Advanced Digital Healthcare to China

    PR Newswire – 11:00 AM ET 06/24/2022

    SHANGHAI, June 24, 2022  Stryker, a leading medical technologies company, attended the 6th World Intelligence Congress in China, showcasing how its Advanced Digital Healthcare solutions brings clinical, operational and financial values for the healthcare market.

  6. Show article details.

    Stocks That Hit 52-Week Lows On Wednesday

    Benzinga – 12:30 PM ET 06/22/2022

      On Wednesday, 329 companies hit new 52-week lows. Here are all the stocks that set new 52-week lows on Wednesday: Be sure to monitor Benzinga for the news traders need!

  7. Show article details.

    If You Invested $1000 In This Stock 20 Years Ago, You Would Have $7,400 Today

    Benzinga – 4:40 PM ET 06/16/2022

    Stryker has outperformed the market over the past 20 years by 3.77% on an annualized basis producing an average annual return of 10.61%. Currently, Stryker has a market capitalization of $73.87 billion. Buying $1000 In SYK: If an investor had bought $1000 of SYK stock 20 years ago, it would be worth $7,406.59 today based on a price of $195.35 for SYK at the time of writing.

  8. Show article details.

    Stocks That Hit 52-Week Lows On Tuesday

    Benzinga – 12:11 PM ET 06/14/2022

      On Tuesday, 951 companies hit new 52-week lows. On Tuesday, the following stocks set new 52-week lows: Be sure to stay with Benzinga for further updates and market-moving news.

  9. Show article details.

    Stocks That Hit 52-Week Lows On Monday

    Benzinga – 12:18 PM ET 06/13/2022

      During Monday's trading, 1214 companies set new 52-week lows. On Monday, the following stocks broke to new 52-week lows: Be sure to monitor Benzinga for the news traders need!

  10. Show article details.

    Stocks That Hit 52-Week Lows On Thursday

    Benzinga – 1:26 PM ET 06/09/2022

      On Thursday, 126 companies set new 52-week lows. On Thursday, the following stocks set new 52-week lows: Be sure to stay with Benzinga for further updates and market-moving news.

  11. Show article details.

    If You Invested $1000 In Stryker 10 Years Ago, Here's How Much You Would Have Today

    Benzinga – 5:20 PM ET 06/02/2022

    Stryker has outperformed the market over the past 10 years by 4.22% on an annualized basis producing an average annual return of 16.42%. Currently, Stryker has a market capitalization of $88.64 billion. Buying $1000 In SYK: If an investor had bought $1000 of SYK stock 10 years ago, it would be worth $4,614.88 today based on a price of $234.40 for SYK at the time of writing.

  12. Show article details.

    6 Stocks To Buy That Are Near 52-Week Lows

    Benzinga – 1:14 PM ET 06/01/2022

    Weakness in the S&P 500 has made life unpleasant for investors so far in 2022, but it has also created buying opportunities in a handful of high-quality stocks. Here are six stocks to buy that are currently trading at or near their 52-week lows, according to Bank of America.

  13. Show article details.

    BRIEF-Stryker Receives FDA Clearance For Q Guidance System For Spine Applications

    Reuters – 9:08 AM ET 05/31/2022

    Stryker Corp (SYK): * STRYKER RECEIVES FDA CLEARANCE FOR Q GUIDANCE SYSTEM FOR SPINE APPLICATIONS Source text for Eikon: Further company coverage:

  14. Show article details.

    Stryker Receives FDA Clearance for Q Guidance System for Spine Applications

    Business Wire – 8:59 AM ET 05/31/2022

    Innovative planning and intraoperative platform designed to be a procedural ecosystem for surgeons and their patients during image-guided surgery Stryker today announced that its Q Guidance System received 510 clearance from the U.S. Food and Drug Administration.

  15. Show article details.

    Medtronic's profit forecast bogged down by supply chain issues

    Reuters – 8:13 AM ET 05/26/2022

    Medical device maker Medtronic Plc (MDT) gave a gloomy profit view for the full year on Thursday after supply chain snarls and strict COVID-19 lockdowns in China slammed quarterly earnings. The dismal results from a major industry player underscore the challenges posed by Beijing's zero-COVID policy, which has hampered production at factories and disrupted businesses.

  16. Show article details.

    Stryker Launches EasyFuse™ Dynamic Compression System for High-Demand Foot and Ankle Applications

    Business Wire – 8:33 AM ET 05/25/2022

    New Nitinol Staple Provides Strength, Efficiency and Ease of Use. Stryker today announced the launch of its EasyFuse™ Dynamic Compression System. This press release features multimedia.

  17. Show article details.

    AeroClean Announces Appointment of Timothy J. Scannell to Board of Directors

    GlobeNewswire – 1:00 PM ET 05/12/2022

    AeroClean Technologies (AERC), a pathogen elimination technology company harnessing patented UV-C LED technology with Pūrgo™ to significantly reduce and remove harmful pathogens to keep work, play and life going, today announced the appointment of Timothy J. Scannell, former President and Chief Operating Officer at Stryker, to its Board of Directors.

  18. Show article details.

    Stryker announces new Investor Relations leader

    GlobeNewswire – 12:00 PM ET 05/05/2022

    Stryker announced today that Jason Beach will be appointed Vice President, Investor Relations and report to Glenn Boehnlein, the company’s Chief Financial Officer, effective July 1, 2022. “I am excited about the commercial experience and financial discipline that Jason will bring to our investor relations team,” said Mr. Boehnlein.

  19. Show article details.

    BRIEF-Stryker Announces Board Changes Following Annual Meeting Of Shareholders

    Reuters – 8:57 AM ET 05/05/2022

    Stryker Corp (SYK): * STRYKER ANNOUNCES BOARD CHANGES FOLLOWING ANNUAL MEETING OF SHAREHOLDERS Source text for Eikon: Further company coverage:

  20. Show article details.

    Stryker announces board changes following Annual Meeting of Shareholders

    GlobeNewswire – 8:00 AM ET 05/05/2022

    Stryker announced that on May 4, 2022, the company’s board of directors approved board leadership and committee assignment changes, naming Sherilyn S. McCoy to replace Allan C. Golston as Lead Independent Director, and Mary K. Brainerd to replace Ms. McCoy as Chair of the Governance and Nominating Committee.

Page:

Today's and Upcoming Events

  • Jul
    26

    SYK to announce Q2 earnings (Confirmed)

Past Events (last 90 days)

  • Jun
    29

    SYK ex-Dividend for $0.70 on 06/29/2022

    • Announce Date: 05/04/2022
    • Record Date: 06/30/2022
    • Pay Date: 07/29/2022
  • Apr
    28

    SYK announced Q1 earnings.

Data provided by Thomson Reuters © 2022

Technical Events

Technical Analysis

PROVIDED BY TRADING CENTRAL
As with all your investments through Fidelity, you must make your own determination whether an investment is appropriate for you. Fidelity is not recommending or endorsing this security by making it available to customers. You should conduct research and perform a thorough investigation as to the characteristics of any securities you intend to purchase. Before investing, you should read the prospectus, offering circular, indenture, or similar document carefully for a full description of the product, including its features and risks, to determine whether it is an appropriate investment for your investment objectives, risk tolerance, financial situation and other individual factors, and be sure to re-evaluate those factors on a periodic basis.

Performance data shown represents past performance, which is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore, you may have a gain or loss when you sell your shares.


Stock markets are volatile and can decline significantly in response to adverse issuer, political, regulatory, market, or economic developments. Growth stocks can be more volatile than other types of stocks. Value stocks can continue to be undervalued by the market for long periods of time. Foreign securities are subject to interest-rate, currency-exchange-rate, economic, and political risks, all of which are magnified in emerging markets. Illiquidity is an inherent risk associated with investing in real estate and REITs. There is no guarantee the issuer of a REIT will maintain the secondary market for its shares and redemptions may be at a price which is more or less than the original price paid. Closed-end funds can trade at a discount to their NAV. Shareholders of Master Limited Partnerships may be treated as partners for tax purposes. Partnerships issue a Schedule K-1 (Form 1065) rather than a Form 1099 form for tax purposes. It lists the partner's share of income, deductions, credits, etc. Speak with your tax advisor to determine how this may affect you. A royalty trust is a type of corporation, mostly in the United States or Canada, usually involved in oil and gas production or mining. Royalty trusts may have special tax treatment, so you should consult a tax advisor on the potential tax consequences of investing in them.

News, commentary and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended for research purposes to help self-directed investors evaluate many types of securities including, but not limited to common stocks, American Depository Receipts, Master Limited Partnerships, real estate investment trusts. traditional preferred stock, trust preferred securities, third-party trust certificates, convertible securities, mandatory convertible securities and other exchange-traded equity and/or debt securities. Criteria and inputs entered, including the choice to make security comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from its use.

462499.6.0
See the Latest Features
Personalized
Get relevant information about your holdings right when you need it.
See Your Performance Click the portfolio icon to get information about stocks you own without leaving the research page.
Faster Access to Positions A shortcut to view the full list of positions in your portfolio? Yes, please! Use the ticker search box.
Add Your Own Notes Use Notebook to save your investment ideas in one convenient, private, and secure place.
Convenient For You
Research that's clear, accessible, and all in one place makes for a better experience.
One-Stop Shop See everything you need to make investment decisions right in the dashboard.
Access Anywhere No matter where you are, use the Stock Research experience across multiple devices.
New Ideas, On the Ready Find new ideas using quick links to the Stock Screener.
New Ways to Research
Discover new tools to add or diversify your existing research strategy.
StockTwits Read live tweets from the financial and investing community about the stock you're interested in.
Fundamental Analysis Save time on research by getting an overall assessment of a company's valuation, quality, growth stability, and financial health.
Recognia Technical Analysis Perfect for the technical trader—this indicator captures a stock's technical events and converts them into short, medium, and long-term sentiment.
Top Competitors See how a stock measures up by instantly comparing it to the industry average and its top four competitors.
Social Sentiment Get a sense of people's overall feelings towards a company in social media with this summary tool.
Earnings Data Monitor earnings expectations over the past three quarters and model a stock's price based on its P/E.